Kimyrsa and Orbactiv – A Tale of Two Formulations
Sign Up to like & getrecommendations! Published in 2023 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s324285
Abstract: Abstract Kimyrsa is a new formulation (NF) of the original formulation of oritavancin ([OF] Orbactiv). Comparatively, the obvious benefit with this product is the shortened infusion time and flexibility with solution compatibility, but otherwise maintains… read more here.
Keywords: orbactiv tale; tale two; kimyrsa orbactiv; two formulations ... See more keywords